we herewith file Non applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 on disclosure of Related Party transactions for the half year ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem has informed the BSE that the disclosure requirement for Related Party Transactions under Regulation 23(9) of SEBI (LODR) does not apply to the company for the half year ended 31 March 2025. The company qualifies for this exemption because its paid-up equity share capital is below Rs. 10 crore and its net worth is below Rs. 25 crore as on the last day of the previous financial year. As a small-cap company falling below these thresholds, it is exempt from several corporate governance provisions under Regulation 15(2). The filing is a routine compliance submission confirming the exemption, and no actual related party transaction data has been disclosed.
No material impact on shareholders or stock price. This is a routine regulatory filing confirming that the company is too small (by capital and net worth) to be required to disclose related party transactions, so there is no new information for investors to act on.